Subscribe to Newsletter

Leader in microbiology innovation

Please log in for more information

 

Read the full article now

Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!

Login
Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Company Information

QuantaMatrix Europe
Villejuif Bio Park
1 Mail du Professeur Georges Mathé
94800 Villejuif, France

[email protected]

QuantaMatrix was founded in 2010 as an ivd company by Dr. Sunghoon Kwon, professor at Seoul National University in Korea. Our mission is to treat sepsis & antibiotics misuse by providing optimal antimicrobial prescription with our dRASTTM platform.

Minimizing time to optimal treatment is directly linked to patient survival., dRASTTM decreases the time to result by 30-50 hours. By reducing exposure to broad-spectrum treatment with dRASTTM, more optimal treatment against bacterial infection is available sooner and prevent antimicrobial resistance. Shortened treatment time helps reducing global healthcare cost with shorter length of stay in hospital.

Our goal is to continue to innovate in microbiology, molecular biology, and immunoassay.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register